Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2026)

Contineum Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $364000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 95.7% year-over-year to $364000.0; the TTM figure through Jun 2026 stood at $364000.0 (up 95.7% YoY), while the FY2025 annual figure was $256000.0, up 8433.33% from the prior year.
• Other Non-Current Assets for Q2 2026 stood at $364000.0, up from $312000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $2.6 million in Q1 2024, with the low at $3000.0 in Q2 2024.
• The 4-year median for Other Non-Current Assets is $256000.0 (2025), against an average of $482090.9.
• Peak annual rise in Other Non-Current Assets reached 8766.67% in 2025, while the deepest fall reached 99.85% in 2025.
• Contineum Therapeutics' Other Non-Current Assets stood at $1.3 million in 2023, then plunged by 99.77% to $3000.0 in 2024, then soared by 8433.33% to $256000.0 in 2025, then surged by 42.19% to $364000.0 in 2026.
• Business Quant data shows CTNM's Other Non-Current Assets at $364000.0 in Q2 2026, $312000.0 in Q1 2026, and $256000.0 in Q4 2025.